Alcon Inc.

NYSE:ALC

Medical - Instruments & Supplies

Healthcare
$75.26 +0.94%

+$0.61 today

Market cap
$36.15B
Beta
0.70
P/E (TTM)
38.7
EPS (TTM)
$1.67
Dividend yield
0.55%
52W Low $61.84High $92.55

Volume 4.74M

Average 1.91M

ALC Debt Repayment

Cash used to repay borrowings during the period.

Alcon Inc.NYSE: ALC

Debt Repayment · Q3 FY2026 · quarter ended Sep 2026

Debt repayment turns positive

Q3 FY2026 debt repayment was $580M, compared with -$2.56M a year earlier. Trailing-twelve-month debt repayment was $540.88M.

Context

  • Debt repayment amounted to 0.9% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Debt repayment increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly debt repayment holds near $580M or moves back toward the trailing-twelve-month quarterly average of $135.22M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$580M+2330.8% QoQ
Last fiscal yearDec 2025
-$96M-29.9% YoY
LTMSep 2026
$540.88M+1001.7% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22731.7%——
1 year-29.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
(96M) USD
Year-over-year change
+29.9%

Debt Repayment vs competitors

How ALC compares with its peers on the latest reported figures

  • ALC's LTM Sep 2026 debt repayment of $540.88M is the largest of the 8 companies compared; the peer median is $0.
  • Its year-over-year change of +1001.7% is the highest of 8, against a peer median of -51.5%.
  • Debt repayment amounts to 4.9% of revenue for ALC, versus a peer median of 0.0%.
ALC Competitors Peer median
Debt Repayment for ALC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$540.88M +1001.7%—4.9%
BLCOBausch + Lomb CorporationLTM Jun 2026$141.75M -51.5%-53.4%2.7%
COOThe Cooper Companies, Inc.LTM Jul 2026$66.2M +142.0%—1.6%
GKOSGlaukos CorporationLTM Jun 2026$526K +131.1%+28.6%0.1%
RXSTRxSight, Inc.LTM Mar 2026$20K -57.4%-40.1%0.0%
STAASTAAR Surgical CompanyLTM Apr 2026$0 +100.0%-30.7%0.0%
SGHTSight Sciences, Inc.LTM Mar 2026$0 -100.0%—0.0%
LNSRLENSAR, Inc.LTM Mar 2026$0 -100.0%—0.0%
Peer median (excluding ALC) $0-51.5%-35.4%0.0%

Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income376M335M974M1.02B980M
Depreciation & Amortization1.22B1.12B1.22B1.23B1.34B
Deferred Income Tax42M128M(142M)238M180M
Stock-Based Compensation138M140M144M150M162M
Change in Working Capital(314M)(522M)(431.22M)(189M)(240M)
Accounts Receivables(198M)(164M)(117.41M)(55M)(129M)
Inventory(326M)(217M)(289.26M)(47M)(156M)
Accounts Payables60M(48M)(54.44M)(15M)116M
Other Working Capital150M(93M)29.89M(72M)(71M)
Other Non-Cash Items(116M)13M(377.78M)(368M)(146M)
Operating Cash Flow1.35B1.22B1.39B2.08B2.27B
Capital Expenditures(1.18B)(745M)(851M)(670M)(663M)
Acquisitions (Net)480M(666M)(10M)(220M)(700M)
Purchases of Investments(19M)(50M)(248.7M)(278M)(136M)
Sales of Investments1M81M2M9M158M
Other Investing Activities(480M)(485M)(177.3M)(205M)(123M)
Investing Cash Flow(1.2B)(1.87B)(1.09B)(1.17B)(1.34B)
Debt Repayment(63M)166M(7M)(137M)(96M)
Common Stock Issued00000
Common Stock Repurchased(22M)(50M)(49M)(47M)(723M)
Dividends Paid(54.11M)(100M)(116M)(130M)(166M)
Other Financing Activities16.11M(24M)(39M)(8M)(134M)
Financing Cash Flow(123M)(8M)(211M)(322M)(1.12B)
Effect of Forex Changes(6M)61M31M(6M)43M
Net Change in Cash18M(595M)114M582M(149M)
Free Cash Flow165M472M537M1.41B1.61B

Alcon Inc.

NYSE:ALC

Intrinsic Alpha fair value

Locked

Current Price

$75.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.